Burkina Faso summary indicators
| Baseline costing indicators | 2001 |
| GDP per capita1 | $203 |
| Population2 | $12,258,634 |
| Surviving infants2 | 524,000 |
| DTP-3 coverage3 | 41% |
| Total health expenditure per capita (Current $)4 | $6.1 |
| Total spending on routine immunization5 | $2,669,793 |
| - per DTP-3 immunized child | $12.4 |
| - per capita | $0.22 |
| - as a % of overall health expenditure | 3.6% |
| Total spending on the NIP (including campaigns)5 | $9,277,199 |
| - as a % of overall health expenditure | 12.4% |
| Future resource requirements, financing and gaps5 | 2003-2006 |
| Avg. annual resource requirements | $15,672,477 |
| - % new-underused vaccines | 21.8% |
| - per DTP-3 targeted child | $31.1 |
| Avg. annual secure funding | $10,449,464 |
| - % from government | 27.5% |
| - % from GAVI-Vaccine Fund | 38.5% |
| - % from other donors | 33.9% |
| Avg. annual probable funding | $1,277,486 |
| Avg. annual funding gap (secure and probable funding) | $3,945,527 |
| - % of resource requirements | 25.2% |
| - per DTP-3 targeted child | $7.8 |
Sources:
- World Development Indicators - World Bank for GDP
- United Nations Population Division, Department of Economic and Social Affairs, World Population Prospects the 2002 Revisions
- WHO-UNICEF Coverage Best Estimates
- WHO - World Health Report 2003
- Immunization Financing Database. Immunization specific spending is reported.